Thyroid nodules are common clinical findings, affecting a significant portion of the population, with studies showing that nearly 50% of individuals over the age of 60 have at least one thyroid nodule detectable via imaging. While the majority of these nodules are benign, a small percentage can be malignant, leading to thyroid cancer. The early detection and accurate diagnosis of thyroid nodules are crucial for appropriate management and treatment. Imaging modalities play a vital role in this process, providing detailed information about the size, structure, and characteristics of nodules, which help in distinguishing between benign and malignant lesions.^1-4

This review explores the various imaging techniques used in the diagnosis and management of thyroid nodules, including their benefits, limitations, and evolving trends. We will discuss traditional imaging methods such as ultrasound, more advanced techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine approaches like scintigraphy and positron emission tomography (PET). Additionally, we will explore the emerging role of artificial intelligence (AI) in the field of thyroid imaging.

Epidemiology and Importance of Thyroid Nodule Diagnosis^5-7

Thyroid nodules are more common in women than in men, with prevalence increasing with age and exposure to risk factors such as iodine deficiency and radiation. While most nodules are benign, the primary clinical concern is the possibility of malignancy. Thyroid cancer is relatively rare compared to the high incidence of benign nodules, but it is the most common malignancy of the endocrine system.

• Prevalence and Risk of Malignancy: About 5% of thyroid nodules are malignant, meaning that the vast majority of nodules do not pose a significant health risk. However, early identification of cancerous nodules can significantly improve outcomes, making imaging a crucial step in the diagnostic pathway.

Imaging Modalities in Thyroid Nodule Diagnosis^1,2,4,8

1. Ultrasound (US)

Ultrasound is the cornerstone imaging modality for evaluating thyroid nodules due to its accessibility, non-invasiveness, and high resolution. It is the first-line tool for the detection and characterization of thyroid nodules, providing critical information about their size, structure, and composition.

Role of Ultrasound in Thyroid Nodule Diagnosis

• Thyroid Ultrasound Characteristics: Ultrasound can differentiate between solid and cystic nodules, and it provides information on the echogenicity, margins, and calcifications within the nodules. Nodules are classified based on their appearance into benign or suspicious categories.
• Benign Features: Isoechoic or hyperechoic nodules, smooth margins, absence of microcalcifications, and purely cystic or spongiform appearance are usually associated with benign conditions.
• Suspicious Features: Hypoechoic nodules, irregular or lobulated margins, microcalcifications, taller-than-wide shape, and increased vascularity are red flags for potential malignancy.
• Thyroid Imaging Reporting and Data System (TI-RADS): To standardize the reporting of thyroid ultrasound findings, the American College of Radiology (ACR) developed the TI-RADS system. This classification stratifies nodules based on their ultrasound characteristics and provides a risk score that guides decision-making regarding fine-needle aspiration (FNA) biopsy.

Advantages and Limitations of Ultrasound

• Advantages:
• High-resolution images of thyroid anatomy.
• Safe for repeated use, as it does not involve ionizing radiation.
• Cost-effective and widely available.
• Can guide FNA biopsy of suspicious nodules.
• Limitations:
• Operator dependency can lead to variability in interpretations.
• Difficulty in assessing posteriorly located nodules or those obscured by overlying tissues.
• Limited ability to assess the extent of large goiters or invasion into surrounding structures.

2. Ultrasound-Guided Fine-Needle Aspiration (FNA)

Ultrasound not only helps in the diagnosis but also plays a critical role in guiding fine-needle aspiration (FNA), which is the gold standard for obtaining tissue samples from thyroid nodules. Ultrasound guidance ensures accurate targeting of the nodule, especially when the lesion is small or difficult to palpate.

• FNA in Nodule Evaluation: FNA is recommended for nodules that exhibit suspicious ultrasound features or are larger than 1 cm. Cytological analysis of the aspirated material helps distinguish between benign and malignant nodules, guiding the clinical management of patients.
• Bethesda System for Reporting Thyroid Cytopathology: This classification system standardizes the reporting of FNA results into six categories, each with an associated risk of malignancy and recommendations for further management.

3. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)

CT and MRI are not typically used for the primary evaluation of thyroid nodules, as ultrasound remains the first-line imaging modality. However, these modalities are invaluable in certain clinical scenarios, particularly when evaluating large goiters, retrosternal nodules, or suspected malignancies with local invasion.

CT in Thyroid Nodule Evaluation

CT is particularly useful in assessing the extent of thyroid malignancies, especially in cases where the tumor invades the trachea, esophagus, or other mediastinal structures. It can provide detailed information about the size and spread of the tumor, which is crucial for surgical planning.

• Advantages:
• Useful for assessing large or retrosternal goiters.
• Provides detailed images of surrounding structures and potential metastases.
• Can assess airway compression or displacement caused by large nodules.
• Limitations:
• Involves exposure to ionizing radiation.
• Requires the use of contrast agents, which may not be suitable for all patients.

MRI in Thyroid Nodule Evaluation

MRI is an alternative to CT for patients who cannot receive iodinated contrast, such as those with contrast allergies or renal insufficiency. It provides excellent soft tissue contrast and is particularly useful in evaluating the extent of thyroid malignancies, particularly in the head and neck region.

• Advantages:
• Superior soft tissue contrast compared to CT.
• No ionizing radiation, making it safer for repeated imaging.
• Effective in assessing local invasion and lymph node involvement.
• Limitations:
• Limited availability and higher cost.
• Longer scan times and sensitivity to motion artifacts.
• Not typically used for routine evaluation of thyroid nodules.

4. Nuclear Medicine Imaging: Scintigraphy and PET

Nuclear medicine plays an essential role in the functional assessment of thyroid nodules, providing information about thyroid activity and metabolism. Two key nuclear imaging techniques used in thyroid nodule evaluation are thyroid scintigraphy and positron emission tomography (PET).

Thyroid Scintigraphy

Thyroid scintigraphy, also known as a thyroid scan, uses radioactive iodine or technetium to assess the functional status of thyroid nodules. The results of a scintigraphy scan classify nodules as either "hot" or "cold," based on their ability to uptake radioactive material.

• Hot Nodules: Nodules that actively take up radioactive iodine are referred to as "hot" nodules and are usually hyperfunctioning (producing excess thyroid hormones). Hot nodules are almost always benign and are commonly associated with hyperthyroidism.
• Cold Nodules: Nodules that do not take up iodine are classified as "cold" nodules and carry a higher risk of malignancy. While the majority of cold nodules are benign, further evaluation with FNA is often recommended to rule out cancer.

Positron Emission Tomography (PET)

PET imaging, particularly when combined with CT (PET-CT), has become an important tool in the evaluation of metastatic or recurrent thyroid cancer. PET is used to detect areas of increased metabolic activity, which may indicate the presence of malignancy, especially in patients with elevated serum thyroglobulin levels but negative radioactive iodine scans.

• Applications of PET:
• Detection of distant metastases in advanced thyroid cancer.
• Evaluation of recurrent disease after thyroidectomy or radioiodine treatment.
• Assessment of radioiodine-refractory thyroid cancers.

Limitations of Nuclear Imaging

• Radiation Exposure: Both thyroid scintigraphy and PET involve radiation exposure, which limits their use in certain populations, such as pregnant women.
• Cost and Availability: PET-CT is expensive and may not be readily available in all healthcare settings. Its use is typically reserved for more complex cases.

Current Trends in Imaging for Thyroid Nodules^8-10

Advancements in imaging technology continue to refine the diagnosis and management of thyroid nodules, leading to improved patient outcomes. Several emerging trends are shaping the future of thyroid nodule imaging.

1. The Role of Elastography

Elastography is an ultrasound-based technique that assesses tissue stiffness. Thyroid elastography measures the elasticity of thyroid nodules, providing additional information that can help differentiate between benign and malignant lesions. Malignant nodules are generally stiffer than benign ones, and elastography can aid in the risk stratification of nodules.

• Applications in Thyroid Nodules:
• Can improve the accuracy of thyroid nodule characterization.
• Useful in conjunction with TI-RADS and FNA results to guide clinical decision-making.

2. Contrast-Enhanced Ultrasound (CEUS)

Contrast-enhanced ultrasound (CEUS) involves the use of microbubble contrast agents to improve the visualization of blood flow within thyroid nodules. CEUS provides detailed information about the vascularity of a nodule, which can help in distinguishing between benign and malignant nodules.

• Advantages of CEUS:
• No ionizing radiation, making it safe for use in pregnant women and children.
• Provides real-time imaging of nodule perfusion and vascular patterns.
• May reduce the need for unnecessary biopsies in benign-appearing nodules.

3. Artificial Intelligence (AI) in Thyroid Imaging

Artificial intelligence (AI) and machine learning algorithms are revolutionizing thyroid imaging by improving diagnostic accuracy and reducing interobserver variability. AI systems can automatically analyze ultrasound images, classify nodules based on risk categories, and recommend further management.

• AI Applications:
• Automated nodule segmentation and classification.
• Real-time risk stratification of nodules based on ultrasound features.
• Integration with clinical decision support systems to provide personalized treatment recommendations.
• Challenges of AI in Thyroid Imaging:
• The need for large, diverse datasets to train AI algorithms.
• Ensuring that AI models generalize well across different populations and healthcare settings.

4. Fusion Imaging Techniques

Fusion imaging combines two or more imaging modalities to provide complementary information about thyroid nodules. For example, ultrasound can be fused with CT or MRI images to enhance the visualization of nodules and surrounding structures. This approach is particularly useful in complex cases where the extent of disease is unclear.

Management of Thyroid Nodules Based on Imaging Findings^9-12

Imaging plays a critical role in guiding the management of thyroid nodules, from initial diagnosis to long-term follow-up. The management of thyroid nodules depends on a combination of imaging findings, FNA biopsy results, and clinical factors.

1. Active Surveillance vs. Surgical Intervention

For benign or low-risk nodules, active surveillance with periodic ultrasound monitoring is often recommended. This approach avoids unnecessary surgery and reduces the risk of complications.

• Criteria for Active Surveillance:
• Nodules with benign cytology on FNA.
• Nodules with low TI-RADS scores.
• Nodules that are asymptomatic and stable in size.

For nodules with suspicious imaging features or confirmed malignancy, surgical intervention, such as thyroidectomy or lobectomy, may be necessary. Imaging is crucial in preoperative planning to assess the extent of the disease and guide the surgical approach.

2. Radiofrequency Ablation (RFA)

For selected benign thyroid nodules, particularly those that cause compressive symptoms or cosmetic concerns, radiofrequency ablation (RFA) has emerged as a minimally invasive alternative to surgery. Ultrasound guidance is used during RFA to precisely target and ablate the nodule, reducing its size and improving symptoms.

• Benefits of RFA:
• Minimally invasive and well-tolerated by patients.
• Preserves normal thyroid tissue.

Suitable for patients with contraindications to surgery

Imaging modalities play a pivotal role in the diagnosis and management of thyroid nodules, from initial detection to treatment planning. Ultrasound remains the first-line imaging tool for thyroid nodules, providing critical information about nodule characteristics and guiding fine-needle aspiration biopsies. Advances in ultrasound technology, such as elastography and contrast-enhanced ultrasound, have further improved the accuracy of nodule assessment.

CT, MRI, and nuclear medicine techniques like scintigraphy and PET provide additional information in cases of suspected malignancy, large goiters, or recurrent disease. Emerging trends, including AI, fusion imaging, and minimally invasive treatments like radiofrequency ablation, are further enhancing the precision and efficiency of thyroid nodule management.

By combining these imaging modalities with clinical and cytological data, healthcare providers can make informed decisions about the most appropriate management strategies for patients with thyroid nodules, ultimately improving patient outcomes and reducing unnecessary interventions.

1. Bomeli SR, LeBeau SO, Ferris RL. Evaluation of a thyroid nodule. Otolaryngol Clin North Am. 2010 Apr;43(2):229-38.
2. Mayo Clinic. Thyroid nodules: diagnosis & treatment. Mayo Clinic. Available from: https://www.mayoclinic.org/diseases-conditions/thyroid-nodules/diagnosis-treatment/drc-20355266.
3. Lee JY, Baek JH, Ha EJ, et al; Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. 2020 Imaging Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer: Korean Society of Thyroid Radiology. Korean J Radiol. 2021 May;22(5):840-860. 
4. Shin JH, Baek JH, Chung J, et al, Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J Radiol. 2016 May-Jun;17(3):370-395.
5. Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):901-11. 
6. Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am. 2012 Mar;96(2):329-49. 
7. Giovanella L, Campennì A, Tuncel M, Petranović Ovčariček P. Integrated Diagnostics of Thyroid Nodules. Cancers. 2024; 16(2):311.
8. Wang L, Yang S, Yang S, et al. Automatic thyroid nodule recognition and diagnosis in ultrasound imaging with the YOLOv2 neural network. World J Surg Onc. 2019;17:12.
9. Chaudhary V, Bano S. Imaging of the thyroid: Recent advances. Indian J Endocrinol Metab. 2012 May;16(3):371-6.
10. Yao W, Peng X, Guan Y, Du X, Xia C, Liu F. Thyroid Nodules: Emerging Trends in Detection and Visualization based on Citespace. Endocr Metab Immune Disord Drug Targets. 2024;24(1):130-141.
11. Tamhane S, Gharib H. Thyroid nodule update on diagnosis and management. Clin Diabetes Endocrinol. 2016 Oct 3;2:17.
12. Uludag M, Unlu MT, Kostek M, Aygun N, Caliskan O, Ozel A, Isgor A. Management of Thyroid Nodules. Sisli Etfal Hastan Tip Bul. 2023 Sep 29;57(3):287-304.